In parallel, we evaluated expression of the AMPKα subunit in animals expressing either an RNAi targeting the γ (γ RNAi) or α (αRNAi) subunits, and observed a significant reduction in the α protein levels in these two genotypes but not in animals possessing the GAL4 alone or in animals expressing an RNAi targeting a different gene (Figure S3).
We also evaluated expression of CCR2 on the surface of THP-1-derived macrophage by flow cytometry.
To further corroborate these findings, we evaluated expression of metastatic markers E-cadherin, Vimentin, Snail and Zeb-1 in these cells upon Irigenin treatment.
We then evaluated expression of bphD.
In the current study, we evaluated expression of MAO subtypes in brain regions of young and aged rats subjected to olfactory bulbectomy (OBX), a procedure that reproduces many of the biochemical and functional changes associated with human depression.
When we evaluated expression of 1479 genes included in Dim1 by Darmanis et al. in our single neuron samples, we found a subset of the genes had enriched expression in our "matured" neuronal samples (Fig. S2).
We also evaluated expression of CD25, an additional marker of activated and regulatory T cells [32].
We previously catalogued and evaluated expression of multiple splicing forms of TCF7L2 in several types of human tissue [21].
In a previous report which evaluated expression of BMCC1-4 (BNIPXL) the BCH domain at the C-terminus, which is homologous to the BCH region of the BNIP2 and BPGAP1 genes, was shown to target Rho proteins with potential to inhibit cellular proliferation [24].
A second limitation of this study is that we evaluated expression of extracellular EpCAM only.
In this study, we further evaluated expression of cyclin D1 in 100 of NSCLC tissues.
